Abusive Use of Anabolic Androgenic Steroids, Male Sexual Dysfunction and Infertility: an Updated Review

Overview

Journal Front Toxicol

Date 2024 May 7

PMID 38711907

Authors

Rafael de Almeida Azevedo

Bruno Gualano

Thiago Afonso Teixeira

Bruno C G Nascimento

Jorge Hallak

Affiliations

Soon will be listed here.

Abstract

The evolving prevalence of anabolic androgenic steroids (AAS) abuse among nonathletes is alarming because of the known harm to an individual's health. Among the adverse effects of AAS abuse, male infertility and sexual dysfunction have been often reported in the literature, but little is known regarding its actual prevalence, possible underpinning mechanisms, and potential treatments either during or post-AAS usage. Thus, the current narrative review summarizes the state-of-art regarding the effects of AAS on male fertility and sexual function. Evidence was gathered from the latest reviews and recent original studies, specifically from prospective cohorts and clinical trials, ultimately resulting in five main topics of discussion. First, AAS usage is briefly characterized by its historical background, main physiological mechanisms, and the most frequently used AAS substances. Second, data on the prevalence of AAS-induced male infertility and sexual dysfunction are described. Third, some new insights on possible underpinning mechanisms of AAS-induced male infertility and sexual dysfunction are thoroughly discussed, with particular attention to histological data derived from animal models and the latest insights from prospective cohorts in humans. Fourth, the potential treatments during and after the AAS usage are presented, highlighting the odds of resolving male infertility and sexual dysfunction. Fifth, future directions on this topic are discussed, focusing on the methodological robustness of scientific studies.

References

Corona G, Maseroli E, Maggi M . Injectable testosterone undecanoate for the treatment of hypogonadism. Expert Opin Pharmacother. 2014; 15(13):1903-26. DOI: 10.1517/14656566.2014.944896. View

Smit D, Buijs M, de Hon O, den Heijer M, de Ronde W . Disruption and recovery of testicular function during and after androgen abuse: the HAARLEM study. Hum Reprod. 2021; 36(4):880-890. DOI: 10.1093/humrep/deaa366. View

Bonnecaze A, OConnor T, Burns C . Harm Reduction in Male Patients Actively Using Anabolic Androgenic Steroids (AAS) and Performance-Enhancing Drugs (PEDs): a Review. J Gen Intern Med. 2021; 36(7):2055-2064. PMC: 8298654. DOI: 10.1007/s11606-021-06751-3. View

Sukhera J . Narrative Reviews: Flexible, Rigorous, and Practical. J Grad Med Educ. 2022; 14(4):414-417. PMC: 9380636. DOI: 10.4300/JGME-D-22-00480.1. View

Sagoe D, Molde H, Andreassen C, Torsheim T, Pallesen S . The global epidemiology of anabolic-androgenic steroid use: a meta-analysis and meta-regression analysis. Ann Epidemiol. 2014; 24(5):383-98. DOI: 10.1016/j.annepidem.2014.01.009. View

Pope Jr H, Wood R, Rogol A, Nyberg F, Bowers L, Bhasin S . Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement. Endocr Rev. 2014; 35(3):341-75. PMC: 4026349. DOI: 10.1210/er.2013-1058. View

Grant B, Kean J, Vali N, Campbell J, Maden L, Bijral P . The use of post-cycle therapy is associated with reduced withdrawal symptoms from anabolic-androgenic steroid use: a survey of 470 men. Subst Abuse Treat Prev Policy. 2023; 18(1):66. PMC: 10640727. DOI: 10.1186/s13011-023-00573-8. View

Anawalt B . Diagnosis and Management of Anabolic Androgenic Steroid Use. J Clin Endocrinol Metab. 2019; 104(7):2490-2500. PMC: 6517163. DOI: 10.1210/jc.2018-01882. View

Pariz J, Hallak J . Effects of caffeine supplementation in post-thaw human semen over different incubation periods. Andrologia. 2016; 48(9):961-966. DOI: 10.1111/and.12538. View

10.

de Hon O, Kuipers H, van Bottenburg M . Prevalence of doping use in elite sports: a review of numbers and methods. Sports Med. 2014; 45(1):57-69. DOI: 10.1007/s40279-014-0247-x. View

11.

Hallak J, Sharma R, Wellstead C, Agarwal A . Cryopreservation of human spermatozoa: comparison of TEST-yolk buffer and glycerol. Int J Fertil Womens Med. 2000; 45(1):38-42. View

12.

Ranganathan P, Mahran A, Hallak J, Agarwal A . Sperm cryopreservation for men with nonmalignant, systemic diseases: a descriptive study. J Androl. 2002; 23(1):71-5. DOI: 10.1002/jand.2002.23.1.71. View

13.

Smit D, de Hon O, Venhuis B, den Heijer M, de Ronde W . Baseline characteristics of the HAARLEM study: 100 male amateur athletes using anabolic androgenic steroids. Scand J Med Sci Sports. 2019; 30(3):531-539. DOI: 10.1111/sms.13592. View

14.

Pope Jr H, Kanayama G, Athey A, Ryan E, Hudson J, Baggish A . The lifetime prevalence of anabolic-androgenic steroid use and dependence in Americans: current best estimates. Am J Addict. 2013; 23(4):371-7. PMC: 3961570. DOI: 10.1111/j.1521-0391.2013.12118.x. View

15.

Gu Y, Wang X, Xu D, Peng L, Cheng L, Huang M . A multicenter contraceptive efficacy study of injectable testosterone undecanoate in healthy Chinese men. J Clin Endocrinol Metab. 2003; 88(2):562-8. DOI: 10.1210/jc.2002-020447. View

16.

Pariz J, Ranea C, Monteiro R, Evenson D, Drevet J, Hallak J . Melatonin and Caffeine Supplementation Used, Respectively, as Protective and Stimulating Agents in the Cryopreservation of Human Sperm Improves Survival, Viability, and Motility after Thawing compared to Traditional TEST-Yolk Buffer. Oxid Med Cell Longev. 2019; 2019:6472945. PMC: 6855016. DOI: 10.1155/2019/6472945. View

17.

Hall S, Conti M, French F, Joseph D . Follicle-stimulating hormone regulation of androgen-binding protein messenger RNA in sertoli cell cultures. Mol Endocrinol. 1990; 4(2):349-55. DOI: 10.1210/mend-4-2-349. View

18.

Green B, Johnson C, Adams A . Writing narrative literature reviews for peer-reviewed journals: secrets of the trade. J Chiropr Med. 2009; 5(3):101-17. PMC: 2647067. DOI: 10.1016/S0899-3467(07)60142-6. View

19.

Windfeld-Mathiasen J, Dalhoff K, Traerup Andersen J, Klemp M, Horwitz A, Horwitz H . Male Fertility Before and After Androgen Abuse. J Clin Endocrinol Metab. 2020; 106(2):442-449. DOI: 10.1210/clinem/dgaa837. View

20.

Nieschlag E, Vorona E . MECHANISMS IN ENDOCRINOLOGY: Medical consequences of doping with anabolic androgenic steroids: effects on reproductive functions. Eur J Endocrinol. 2015; 173(2):R47-58. DOI: 10.1530/EJE-15-0080. View